# 11.7 References for Reading 4

Horton, R. (2004) ‘The lessons of MMR’, The Lancet, 363, 6 March 2004, pp 747–749 Elsevier. Copyright © 2004 Elsevier.

1. Murch, SH, Anthony, A, Cassen, DH, et al. ‘Retraction of an interpretation’. Lancet 2004; 363:750.

2. Wakefield, AJ, Murch, SH, Anthony, A, et al. ‘Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children’. Lancet 1998; 351:637–41.

3. Horton, R. ‘A statement by the editors of The Lancet’. Lancet 2004; 363: 820–21.

4. Kanner, L. ‘Autistic disturbances of affective contact’. Nervous Child 1943; 2: 217–50.

5. Volkmar, FR, Pauls, D. ‘Autism’. Lancet 2003;362:1133–41.

6. Goode, E. ‘Autism cases up; cause is unclear’. New York Times Jan 26, 2004: A1.

7. Volkmar, FR, Cohen, DJ. ‘Disintegrative disorder or “late onset” autism’. J Child Psychol Psychiatry 1989; 30:717–24.

8. MRC review of autism research: epidemiology and causes. London: MRC, 2001.

9. Farthing, M, Horton, R, Smith, R. ‘UK's failure to act on research misconduct’. Lancet 2000; 356:2030.

10. Jefferson, T, Price, D, Demicheli, V, et al. ‘Unintended events following immunisation with MMR: a systematic review’. Vaccine 2003; 21:3954–60.

11. Jefferson, T. ‘Informed choice and balance are victims of the MMR-autism saga’. Lancet Infect Dis 2004; 4: 135–36.

12. Editorial. ‘This orchestrated campaign must not be allowed to stifle real debate on MMR’. The Independent Feb 24, 2004: 16.

13. Torrente, F, Anthony, A, Heuschkel, RB et al. ‘Focal enhanced gastritis in regressive autism with features distinct from Crohn's and Helicobacterpylori gastritis’. Am J Gastroenterol (in press).

14. DeFelice, ML, Ruchelli, ED, Markowitz, JE, et al. ‘Intestinal cytokines in children with pervasive developmental disorders’. Am J Gastroenterol 2003; 98: 1777–82.

15. Shapin, S. A social history of truth. Chicago: University of Chicago Press, 1995.

16. Roberts, KA, Dixon-Woods, M, Fitzpatrick, R, Abrams, KR, Jones, DR. ‘Factors affecting uptake of childhood immunisation: a Bayesian synthesis of qualitative and quantitative evidence’. Lancet 2002; 360: 1596–99.

17. Davidoff, F, DeAngelis, CD, Drazen, JM, et al. ‘Sponsorship, authorship, and accountability’. Lancet 2001;358: 854–56.

18. James, A, Horton, R. ‘The Lancet policy on conflicts of interest’. Lancet 2003;361: 8–9.

19. James, A, Horton, R, Collingridge, D, McConnell, J, Butcher, J. ‘The Lancet's policy on conflicts of interest-2004’. Lancet 2004; 363:2–3.

20. Editorial. ‘Dissent must be aired’. Times Higher Educational Supplement Feb 27, 2004: 14.

21. McBride, WG. ‘Thalidomide and congenital abnormalities’. Lancet 1961; ii: 1358.

22. Calman, KC. ‘Communication of risk: choice, consent, and trust’. Lancet 2002;360:166–68.

23. Anonymous. ‘MMR vaccine-how effective and how safe?’ Drug Ther Bull 2003; 41: April, 1–6.

OpenLearn - The MMR vaccine: Public health, private fears
Except for third party materials and otherwise, this content is made available under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 Licence, full copyright detail can be found in the acknowledgements section. Please see full copyright statement for details.